Efficacy of Bevacizumab in Preventing Acute Respiratory Distress Syndrome (ARDS)

NCT01314066 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped No funding

Conditions

Severe Sepsis
Acute Respiratory Distress Syndrome

Interventions

DRUG: Bevacizumab
DRUG: Placebo

Sponsor

Weill Medical College of Cornell University